New York, United States
Research view
Psoriasis: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
EU-13 is a filter, not a ranking: it only narrows the list.
Toronto, Canada
London, United Kingdom
Los Angeles, United States
Dallas, United States
Manchester, United Kingdom
New Haven, United States
Shanghai, China
Cambridge, United States
Paris, France
Beijing, China
Berlin, Germany
San Francisco, United States
Shanghai, China
Changsha, China
Hangzhou, China
Waterloo, Canada
Guangzhou, China
Changsha, China
Shanghai, China
Boston, United States
Manchester, United Kingdom
Philadelphia, United States
Manchester, United Kingdom
24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Suspended
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
“Administrative”Registry text, quoted unchanged. Source
Terminated
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
“Sponsor decision”Registry text, quoted unchanged. Source
Terminated
“Due to the company's strategic adjustment in product portfolio, this study has been voluntarily terminated.”Registry text, quoted unchanged. Source
Terminated
“Study terminated due to insufficient enrollment.”Registry text, quoted unchanged. Source
Terminated
Local Methotrexate Injections for the Treatment of Nail Psoriasis
“The study was terminated due to slow accrual.”Registry text, quoted unchanged. Source
Terminated
“Business objectives have changed”Registry text, quoted unchanged. Source
Terminated
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
“reprioritization”Registry text, quoted unchanged. Source
Withdrawn
“Sponsor decision”Registry text, quoted unchanged. Source
Withdrawn
Pregnancy and Medically Assisted Conception in Rare Diseases
“Abandonment of the study project”Registry text, quoted unchanged. Source
Terminated
“AnaptysBio has concluded the GEMINI-2 trial, with all trial participants having been treated with imsidolimab for approximately six months and the furthest subject having been treated through 104 weeks.”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis
A Long-term Extension Study of Ustekinumab in Pediatric Participants
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 28
- Mendelian Randomization Analysis 38
- CRISPR-Cas Systems 4
- Gene Expression Profiling 66
- Sequence Analysis, RNA 6
- Exome Sequencing 5
- Proteomics 24
- Metabolomics 13
- Flow Cytometry 11
- Immunohistochemistry 24
- Xenograft Model Antitumor Assays 1
- Positron-Emission Tomography 1
- Magnetic Resonance Imaging 23
- Machine Learning 27
- Deep Learning 4
- Cohort Studies 63
- Genome-Wide Association Study 38
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.